Filter
68
Filtered Results: 68
Text search:
Hallucinogens
Featured
Recommendations
3
New Publications
8
Language
Document type
No document type
50
Guidelines
9
Studies & Reports
4
Manuals
1
Brochures
1
Situation Updates
1
Resource Platforms
1
Strategic & Response Plan
1
Countries / Regions
Kenya
4
Western and Central Europe
4
Ukraine
2
Global
2
Sierra Leone
1
Nigeria
1
Africa
1
Latin America and the Carribbean
1
Eastern Europe
1
Moldova
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Countries
8
Clinical Guidelines
2
Public Health
1
Key Resources
1
Toolboxes
Mental Health
41
HIV
10
Refugee
2
Specific Hazards
1
Disability
1
Ebola & Marburg
1
Pharmacy
1
NCDs
1
The WHO Global Burden of Disease (GBD) study measures the burden of
disease using the disability-adjusted life year metric (DALY). The DALY metric
was developed to assess the burden of disease consistently across diseases,
risk factors and regions. A consistent and comparative description of the ...
Manual for use in primary care.
This manual explains the theoretical basis and evidence for the effectiveness of brief interventions and assists primary health care workers in conducting a simple brief intervention for clients whose substance use is putting them at risk.
Accessed: 28.03.2019
Introduction
Chapter A.5
These guidelines were developed as part of Kenya's fast-track plan to end AIDS among adolescents and young people. Based on research into adolescent and young key populations in Kenya and elsewhere, they outline a package of HIV prevention services, and emphasize the need to combine biobehavioural i...
Amphetamine-type stimulants, new psychoactive substances
-4-
World Drug Report 2017
Accessed: 14.03.2019
A Meand to enhancing HIV prevention in key populations. This document has been developed out of the increasing need to set up standards and procedures to prevent and respond to violence against key populations.
Provides clinical descriptions, diagnostic guidelines, and codes for all mental and behavioural disorders commonly encountered in clinical psychiatry. The book was developed from chapter V of the Tenth Revision of the International Statistical Classification of Diseases and Related Health Problems (...
2016 Update
Key population
The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalised anxiety and sleep disorders; obsessive-compulsive disorders and panic attacks; and alcohol and opioid dependence
MMWR Morbidity and Mortality Weekly Report December 19, 2014 / 63(50);1205-1206
Perspectives sur les drogues
Introduction
Chapitre A.5
Edition en français
Traduction : Eleanor O’Boyle
Sous la direction de : Priscille Gérardin
Avec le soutien de la SFPEADA
Le présent document vise à sensibiliser le corps médical ainsi que les autres intervenants de la santé et du social à la situation souvent précaire des réfugiés traumatisés ainsi qu’à encadrer leur pratique. Il dispense des connaissances générales et donne des pistes utiles p...
Non-Wood Forest Products 11
Traditional medicine and its use of medicinal plants is dependent on reliable supply of plant materials. The book focuses on the interface between medicinal plant use and conservation of medicinal plants.
Куріння, вживання алкоголю та наркотичних речовин серед підлітків, які навчаються: поширення й тенденції в Україні : За результатами дослідження 2015 року в рамках м...
While the ratification of the Convention and its Optional Protocol has proceeded rapidly, knowledge on how to implement and monitor them has not kept pace. Conscious of this challenge, my Office has developed this Training Guide on the Convention and its Optional Protocol. It is complemented by eigh...
Autres troubles
Chapitre H.5
Edition en français Traduction : Bojan Mirkovic Sous la direction de : Priscille Gérardin Avec le soutien de la SFPEADA
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its special insights, at assisting Member States in anticipating and address-ing threats from drug markets an...
